Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
67%(2 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Product Preference With Systane Compared to Artificial Tears on Frequency of Drop Use

NCT00347984
completednot_applicable

Acute Comfort and Blur of Systane Ultra and Systane

NCT00748865
completednot_applicable

Acute Comfort and Blur of Systane and Optive

NCT00568386

Clinical Trials (3)

Showing 3 of 3 trials
NCT00347984Not Applicable

Product Preference With Systane Compared to Artificial Tears on Frequency of Drop Use

Completed
NCT00748865Not Applicable

Acute Comfort and Blur of Systane Ultra and Systane

Completed
NCT00568386Not Applicable

Acute Comfort and Blur of Systane and Optive

Completed

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3